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e86 Lettersdescribed, by Papini et al1 in an 8-year-old boy and
by Winnock et al2 in a 43-year-old man. In these 2
cases, dapsone was prescribed without recurrence.
Interestingly, M pneumoniaeeinduced Stevens-
Johnson syndrome with subcorneal pustules has
been described a few times.3-5 However, in our
observation mucous membranes were spared,
rendering Stevens-Johnson less plausible. We sug-
gest that there may be a specific presentation of SPD
of infectious origin, possibly more frequent in young
patients. Our observation highlights the importance
of looking for M pneumoniae in cases of SPD, even
without respiratory symptoms, and suggests topical
treatment for a few weeks may be sufficient if the
eruption is considered secondary to M pneumoniae
infection.
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http://dx.doi.org/10.1016/j.jaad.2014.02.038Rapid deterioration in a patient with primary
aggressive cutaneous epidermotropic CD81
cytotoxic T-cell (‘Berti’) lymphoma after
administration of adalimumab
To the Editor: Primary aggressive cutaneous
epidermotropic CD81 cytotoxic T-cell lymphoma,Open access under CC BY-NC-ND license.a World Health Organization provisional entity here
referred to as ‘‘Berti lymphoma,’’ comprises less than
1% of cutaneous T-cell lymphomas (CTCLs).1
Berti lymphoma classically presents as eruptive
hyperkeratotic plaques or nodules with a phase
of ulceration and necrosis.2 The epidermis
exhibits epidermotropism of atypical pleomorphic
lymphocytes and occasional necrotic keratinocytes.2
Dissemination to lung, testis, central nervous system,
and oral mucosa with sparing of lymph nodes is
common.3 We present a case of Berti lymphoma that
arose following a trial of adalimumab in the setting
of a long-standing spongiotic and psoriasiform
dermatitis clinically suggestive of psoriasis.
A 35-year-old African American woman had a
10-year history of nonspecific ‘‘dermatitis.’’ In the
year before her death, she was admitted to her local
hospital several times for shortness of breath
and dermatitis and was repeatedly treated with
prednisone. Skin biopsies from this period showed
a nonspecific spongiotic and psoriasiform dermatitis.
Immunohistochemical analysis failed to demonstrate
any concerning atypical or CD81 epidermotropic
infiltrate. She was seen by a local dermatologist
as an outpatient, psoriasis was diagnosed, and a
single loading dose of adalimumab (80 mg) was
administered. She presented 2 days later to her
local hospital for respiratory decline and rapidly
developing cutaneous ulceration.
On transfer to our institution’s intensive care unit 6
days later, examination revealed skin ulcers localized
primarily to the trunk as well as serpiginous to
arcuate scaly plaques and erosions on the extremities
(Fig 1). A biopsy on an ulcer edge revealed an
epidermotropic infiltrate of atypical CD81 cells
consistent with a diagnosis of Berti lymphoma
(Fig 2). Atypical cells stained diffusely positive by
immunohistochemistry for CD3, CD8, granzyme B,
and TIA-1, with 70% of cells proliferating by Ki-67. A
subpopulation of atypical cells were CD56 positive.
Atypical cells were negative for CD4, CD5, CD7,
CD20, CD30, CD57, CD99, HSV, and TdT. Flow
cytometry of peripheral blood was normal, and
HTLV I/II and EBV were negative. Left upper and
lower lung biopsies revealed focal involvement by
CD81 and CD561 atypical large lymphocytes
consistent with pulmonary lymphoma. Respiratory
function deteriorated, and she died 2 months after
admission.
Adalimumab, a human tumor necrosis factor
(TNF)-alpha monoclonal antibody, is indicated to
treat a range of autoimmune diseases including
psoriasis.4 Whether TNF-alpha blockade is
associated with development of lymphomas is
controversial, but rapid and fatal progression of
Fig 1. Primary aggressive CD81 cytotoxic T-cell (Berti)
lymphoma following adalimumab. Extremity with papu-
losquamous plaques clinically suggestive of psoriasis.
Fig 2. Biopsy of an ulcer on the chest exhibited
an epidermotropic CD81 infiltrate of atypical T-cells.
(Hematoxylin-eosin stain; original magnification 310.)
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Letters e87lymphomas after TNF-alpha blockade has been
reported.4,5 TNF-alpha blockade likely inhibits both
innate and acquired immunity and may compromise
immune surveillance for malignancy.5
The relation between our patient’s dermatitis
and her Berti lymphoma is unclear. Her dermatitis
may have represented a smoldering CTCL that
transformed into Berti lymphoma, or the latter
may have developed anew in the setting of
immunosuppression.
This case suggests that corticosteroid-refractory,
histologically nonspecific dermatitis should be
evaluated carefully and managed cautiously. Not all
psoriasiform dermatitis is psoriasis or is safely treated
as such. A high suspicion for possible CTCL and a
low threshold for repeat biopsies to establish a
diagnosis should be maintained when considering
immunomodulatory therapy.
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To the Editor: A 30-year-old Caucasian woman
presented to the emergency department in June
with a 5-day history of flu-like symptoms. She denied
recent travel from her residence, Columbiana,
Alabama. She was in her usual state of health until
she experienced a tick bite on her forearm 7 days
before admission. Following tick removal, she
noticed fatigue, myalgias, arthralgias, and severe
headache, with retro-orbital pain. A temperature up
to 1058F recalcitrant to antipyretics accompanied her
symptoms.
On examination, the patient was febrile with
a temperature of 105.78F. Although she was
hemodynamically stable, notable laboratory results
included thrombocytopenia ( platelets: 133,000109/L).
No maculopapular rash was noted. An ulcerated
nodule with a central eschar was noted on her right
forearm (Fig 1). The eschar was biopsied by punch
technique with half of the specimen processed
routinely, while the other half was snap frozen in
liquid nitrogen and sent to the Centers for Disease
Control and Prevention (CDC) for further study.
